Carotid artery stenting has been proposed as an option treatment of carotid artery stenosis. The aim of this single-institution study is to compare the dual-antiplatelet treatment and heparin combined with acetyl-acetic acid, in patients who underwent carotid artery stenting. We compared 2 groups of 50 patents each who underwent carotid artery stenting for primary atherosclerotic disease. Group A received heparin for 24 h combined with 325 mg acetyl-acetic acid and group B received 250 mg ticlopidine twice a day combined with 325 mg acetyl-acetic acid. Outcome measurements included 30-day bleeding and neurological complications and 30-day thrombosis/occlusion rates. The neurological complications were 16% in group A and 2% in group B (p < 0.05). Bleeding complications occurred in 4% in group A and 2% in group B (p &rt; 0.05). The 30-day thrombosis/occlusion rate was 2% in group A and 0% in group B (p &rt; 0.05). Dual antiplatelet treatment is recommended in all patients undergoing carotid artery stenting.
Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting / I. DALAINAS, G. NANO, P. BIANCHI, S. STEGHER, G. MALACRIDA, D.G. TEALDI. - In: CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. - ISSN 0174-1551. - 29:4(2006), pp. 519-521.
Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting
G. NANOSecondo
;D.G. TEALDIUltimo
2006
Abstract
Carotid artery stenting has been proposed as an option treatment of carotid artery stenosis. The aim of this single-institution study is to compare the dual-antiplatelet treatment and heparin combined with acetyl-acetic acid, in patients who underwent carotid artery stenting. We compared 2 groups of 50 patents each who underwent carotid artery stenting for primary atherosclerotic disease. Group A received heparin for 24 h combined with 325 mg acetyl-acetic acid and group B received 250 mg ticlopidine twice a day combined with 325 mg acetyl-acetic acid. Outcome measurements included 30-day bleeding and neurological complications and 30-day thrombosis/occlusion rates. The neurological complications were 16% in group A and 2% in group B (p < 0.05). Bleeding complications occurred in 4% in group A and 2% in group B (p &rt; 0.05). The 30-day thrombosis/occlusion rate was 2% in group A and 0% in group B (p &rt; 0.05). Dual antiplatelet treatment is recommended in all patients undergoing carotid artery stenting.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.